SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File
Reports Under Section 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 000-19809
--------------------------------
Dura Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
7475 Lusk Boulevard, San Diego, California, 92121
(800) 859-8585
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
Common Stock, $.001 par value per share
Rights to Purchase Common Stock
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
--------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) / / Rule 12h-3(b)(1)(ii) / /
Rule 12g-4(a)(1)(ii) / / Rule 12h-3(b)(2)(i) / /
Rule 12g-4(a)(2)(i) / / Rule 12h-3(b)(2)(ii) / /
Rule 12g-4(a)(2)(ii) / /
Rule 12h-3(b)(1)(i) /X/ Rule 15d-6 / /
Approximate number of holders of record as of the certification or notice
date: One
--------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934 Dura
Pharmaceuticals, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
DATE: November 9, 2000 By: /s/Cam L. Garner
---------------- ----------------------------------------
Name: Cam L. Garner
Title: Chairman and Chief Executive
Officer
